Drugmakers could be hit by the coronavirus. India is especially vulnerable
CNNLondon CNN Business — Drugmakers in India are bracing for potential disruption from the coronavirus. “A lot of our pharma value chain is linked to China,” Umang Vohra, the CEO of generics producer Cipla, told investors on February 5. “Many of the raw materials, which we may be buying in India, may have dependence on the Chinese intermediate,” Dilip Shanghvi, the company’s managing director, said during an earnings conference call on February 6. “So we think we are buying from India, but there is a China link.” Global implications Jens Spahn, the German health minister, warned Thursday that the outbreak could lead to drug shortages in Europe. With a majority of some US medical supplies coming from or originating in China, the coronavirus could have “chilling implications” for supply chains, according to Robert Kadlec, assistant secretary at the US Department of Health and Human Services.